In a male patient presenting with an axillary mass, what is the appropriate diagnostic approach?

Diagnostic Approach for Male Patient with Axillary Mass

Axillary ultrasound is the initial imaging modality of choice for a male patient presenting with an axillary mass, with ultrasound-guided biopsy performed if suspicious features are identified. 1

Initial Imaging Strategy

The diagnostic approach mirrors that used in female patients, as the ACR Appropriateness Criteria guidelines apply to both sexes when evaluating axillary masses 1. Ultrasound is the most appropriate first-line imaging test because it can:

• Differentiate solid from cystic masses
• Characterize lymph node morphology (cortical thickness, presence/absence of fatty hilum)
• Guide percutaneous biopsy when indicated
• Identify accessory breast tissue or other soft tissue lesions 1

Multiple studies support ultrasound's utility in characterizing axillary findings, though the malignancy rate in patients without other signs of malignancy is relatively low (approximately 7% in one study of 171 patients) 1.

Key Ultrasound Features Suggesting Malignancy

When performing axillary ultrasound, look for these high-risk features:

• Cortical thickness >0.3 cm
• Short-axis diameter >1 cm
• Absence of fatty hilum (highest positive predictive value at 90-93% for malignancy) 1

If any suspicious features are present, proceed directly to ultrasound-guided core needle biopsy (superior to fine needle aspiration, with 88% sensitivity) 1.

Complementary Imaging Considerations

When to Add Mammography

Mammography is not the initial test but should be added as a complementary study if:

• There is suspicion for breast primary malignancy
• The patient has risk factors for breast cancer (yes, males can develop breast cancer)
• Ultrasound reveals suspicious adenopathy suggesting metastatic disease 1

Important caveat: While male breast cancer is rare, occult breast cancer presenting as isolated axillary adenopathy does occur in males 2. The mean age for malignant axillary pathology is approximately 55 years versus 43 years for benign causes 3.

When to Consider CT Chest

Reserve CT imaging for specific scenarios:

• Suspected chest wall invasion
• Need to assess bony involvement
• Evaluation for systemic lymphadenopathy if lymphoma suspected
• Incidental finding on prior CT requiring further characterization 1

Role of PET/CT

Do not use FDG-PET/CT as initial imaging for an axillary mass of unknown etiology—it has low yield without first confirming malignant etiology 1. Less than 1% of breast cancers initially present as axillary adenopathy 1.

Differential Diagnosis Framework

The differential for male axillary masses includes:

Benign etiologies:

• Reactive lymphadenopathy (infectious/inflammatory)
• Lipomas
• Epidermal inclusion cysts
• Accessory breast tissue with fibroadenoma 4, 5
• Nerve sheath tumors 1

Malignant etiologies:

• Occult breast cancer (including from accessory breast tissue) 2, 6
• Lymphoma
• Metastatic disease from non-breast primary
• Sweat gland carcinoma 6

Clinical Pitfalls to Avoid

1. Don't assume benign based on age alone—while younger patients more commonly have benign pathology, malignancy occurs across age groups 3

2. Don't skip biopsy for "reactive-appearing" nodes—if ultrasound shows suspicious features, tissue diagnosis is essential even with a plausible infectious history 1

3. Don't forget male breast cancer exists—though rare, occult male breast cancer presenting as axillary adenopathy is well-documented 2, 7

4. Don't order extensive staging workup before tissue diagnosis—confirm malignancy first before pursuing systemic imaging 1

Algorithmic Approach

1. Perform axillary ultrasound first 1
2. If benign-appearing (preserved fatty hilum, thin cortex <0.3 cm): Consider observation or short-interval follow-up based on clinical context
3. If suspicious features present: Proceed to ultrasound-guided core needle biopsy 1
4. If malignancy confirmed: Add bilateral mammography to evaluate for breast primary 8, 7
5. If adenocarcinoma of unknown primary: Consider MRI breast if mammography negative (detects occult breast cancer in >66% of cases) 1
6. If non-breast malignancy suspected: Pursue appropriate systemic staging based on pathology results

This structured approach prioritizes tissue diagnosis while avoiding unnecessary radiation exposure and cost from advanced imaging that rarely changes initial management.